Pleno Inc. introduced the Raptix PGx Panel, a new pharmacogenomic testing platform specifically designed for the RAPTOR platform, featuring 331 biomarkers, 55 genes, and a single-day assay.
Published
Signal category
Products & Services
Quote
“Introducing the Raptix™ PGx Panel. Created specifically for the RAPTOR® platform, it brings speed, scale, and simplicity to pharmacogenomic testing.”
— Pleno Inc. team
Company
Pleno Inc.
Targeted biological information at unprecedented scale, precision and performance.
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 44 employees
Pleno Inc. is an early-stage San Diego startup company developing a multi-omic instrument platform to revolutionize biological target detection for clinical testing and biomedical research and enable a broad array of applications from screening and detection, to diagnostics, prognostics and beyond. We are driven and dedicated scientists, engineers and business professionals. We’re developing an innovative and disruptive multi-omic instrument platform that’s going to transform the insights from and application of biological information. We’re in an exciting growth phase and are actively expanding our team. Join us to experience the energy and excitement of taking on the biggest challenges in biosciences and biotechnology to develop innovative solutions that will disrupt the industry. You’ll have the support to flourish both professionally and personally, where your ideas are valued and your commitment and collaboration is key to our success.